We use cookies to help us improve the website and your experience using it. You may delete and block all cookies from this site at any time. However, please note this may result in parts of the site no longer working correctly. If you continue without changing your settings we will assume you are happy to receive all cookies on this site.


Citilab – The new name for the Former Royal Eye Hospital

New Exterior

Today, Bruntwood announced that they are rebranding the Former Royal Eye Hospital as Citilab.

Citilab is a new 100,000 sq ft biomedical centre of excellence, located on Oxford Road at the heart of Europe's largest clinical academic campus. It will attract biohealth companies to develop new products and services designed to meet the needs and expectations of patients.

In addition Bruntwood has confirmed a number of pre-lets: to TRUSTECH, an NHS organisation which aims to improve healthcare through the development of innovative products and services; to The Manchester College who will use the space for medical training; and to The Central Manchester University Hospitals NHS Foundation Trust Charity. The rest of the space has been purpose built for wards for clinical trials, biomedical laboratories and areas for networking.

Chris Oglesby, Chief Executive of Bruntwood said, "The science agenda and growing our customer base in this sector are important parts of Bruntwood's growth plans. We are delighted to announce both the new name, Citilab, alongside welcoming new customers to our portfolio. We are looking forward to working in partnership with them and supporting their plans."

Sir Richard Leese, Leader of Manchester City Council added, "This is an exciting and strategically important development which supports growth and job creation in Manchester".

Mike Deegan, Chief Executive of  Central Manchester University Hospitals NHS Foundation Trust, added: "I'm really pleased that this unused building is being developed by Bruntwood into a centre of excellence for innovation that will enable companies to work with us to develop new treatments to help the NHS patients - it will also be good for the city region economy."